Although we have not analysed the mechanisms by which TLR4 blockade improves the IL-1β-induced endothelial dysfunction, the reduction of oxidative stress might contribute to this effect, as has been reported in the hypertension-associated endothelial dysfunction (Hernanz et al., 2015). The gene discussed is TLR4; the disease is hypertensive disorder.